{"created":"2023-05-15T14:36:12.509137+00:00","id":46607,"links":{},"metadata":{"_buckets":{"deposit":"4c29ab5e-28e1-4bb5-820b-292edd5694d4"},"_deposit":{"created_by":1,"id":"46607","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"46607"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00046607","sets":["1"]},"author_link":["464617","464621","464619","464616","464618","464620","464615"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"4","bibliographicPageEnd":"577","bibliographicPageStart":"574","bibliographicVolumeNumber":"18","bibliographic_titles":[{"bibliographic_title":"International Journal of Clinical Oncology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"BACKGROUND: To clarify how a multidisciplinary cancer board (CB) influences treatment decisions.\n\\nMETHODS: From March 2010 to June 2011, a total of 475 cases were discussed at our CB and the minutes of the board were reviewed for this study.\n\\nRESULTS: Of the 475 patients, minor changes in treatment methods were made in 42 patients (9 %) and major changes were made in 28 patients (6 %). Further diagnostic procedures, further publication surveys and reconfirmation of patient's wishes were recommended in 80 patients (17 %). In the 392 patients for whom treatment was recommended, the CB's recommendation was realized in 349 patients (89 %) and was not realized in 20 (5 %) patients.\n\\nCONCLUSIONS: It is obvious that a CB has a great influence on cancer treatment decisions, but the effectiveness of the CB in our hospital should be verified in the future by analyzing treatment outcomes.","subitem_description_type":"Abstract"}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s10147-012-0420-x","subitem_relation_type_select":"DOI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1341-9625","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Nemoto, Kenji"}],"nameIdentifiers":[{"nameIdentifier":"464615","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Murakami, Misako"}],"nameIdentifiers":[{"nameIdentifier":"464616","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ichikawa, Mayumi"}],"nameIdentifiers":[{"nameIdentifier":"464617","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ota, Ibuki"}],"nameIdentifiers":[{"nameIdentifier":"464618","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nomiya, Takuma"}],"nameIdentifiers":[{"nameIdentifier":"464619","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"et.al"}],"nameIdentifiers":[{"nameIdentifier":"464620","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"野宮 琢磨","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"464621","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Influence of a multidisciplinary cancer board on treatment decisions.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Influence of a multidisciplinary cancer board on treatment decisions."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-10-17"},"publish_date":"2013-10-17","publish_status":"0","recid":"46607","relation_version_is_last":true,"title":["Influence of a multidisciplinary cancer board on treatment decisions."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T23:49:45.537246+00:00"}